chapter 4 - neuropharmacology

69
Neurophysiology, Neurophysiology, Neurotransmitters Neurotransmitters and the Nervous and the Nervous System System

Upload: dominic54

Post on 08-May-2015

844 views

Category:

Documents


5 download

TRANSCRIPT

Page 1: Chapter 4 - Neuropharmacology

Neurophysiology, Neurophysiology, Neurotransmitters and the Neurotransmitters and the

Nervous SystemNervous System

Page 2: Chapter 4 - Neuropharmacology

The NeuronThe Neuron

The nervous system is made of nerve cells or neurons and glial cells. Glial cells are not excitable and provide metabolic and physical support for the neurons. 90% of the cells are glial cells. Neurons are excitable and control behavior

Page 3: Chapter 4 - Neuropharmacology

NeuronNeuron

Page 4: Chapter 4 - Neuropharmacology

Resting potentialResting potential

Page 5: Chapter 4 - Neuropharmacology

Resting potentialResting potential

There is a potential difference between the inside and outside of as membrane. The inside is about -70 mv relative to the outside.

Page 6: Chapter 4 - Neuropharmacology

Resting PotentialResting PotentialThe resting potential is caused by an uneven distribution of ions (electrically charged molecules) of potassium (K+) and sodium (Na+) and chloride (Cl-).

This is caused by Na+/K+ ion pumps that move 3 Na+ ions out of the cell for every 2 K+ ions it moves in.

Therefore there are more +ions outside the cell than inside and the inside is negatively charged with respect to the outside

Page 7: Chapter 4 - Neuropharmacology

Ion pumpIon pump

Page 8: Chapter 4 - Neuropharmacology

Resting potentialResting potential

An ion channel is a combination of large protein molecules that cross the membrane and allow specific ions to pass through at a specific rate,

These allow enough leakage of ions to mostly neutralize the effect of the ion pump, but

Page 9: Chapter 4 - Neuropharmacology

Ion channelsIon channels

Page 10: Chapter 4 - Neuropharmacology

Resting potentialResting potential

Forces maintaining the resting potentialForces maintaining the resting potential Diffusion pressure – molecules want to move Diffusion pressure – molecules want to move

from areas of high concentration to areas of from areas of high concentration to areas of low concentration.low concentration.

Electrostatic charge – ions with like charge Electrostatic charge – ions with like charge are repelled and ions with a different charge are repelled and ions with a different charge are attracted.are attracted.

Operation of ion pumps and ion channels. Operation of ion pumps and ion channels.

Page 11: Chapter 4 - Neuropharmacology

Action potentialAction potential

Anything that alters the functioning of the ion Anything that alters the functioning of the ion channels can change the resting potential.channels can change the resting potential.

If changes cause the resting potential to be If changes cause the resting potential to be reduced, this is called reduced, this is called depolarization.depolarization.

If the change causes an increase in the resting If the change causes an increase in the resting potential, this is caused potential, this is caused hyperpolarizationhyperpolarization..

Page 12: Chapter 4 - Neuropharmacology

Action PotentialAction Potential

We can insert an electrode across a We can insert an electrode across a membrane and cause depolarization, i.e., membrane and cause depolarization, i.e., we can depolarize the cell.we can depolarize the cell.

If we reduce the resting potential past a If we reduce the resting potential past a thresholdthreshold, the resting potential breaks , the resting potential breaks down.down.

Page 13: Chapter 4 - Neuropharmacology

Action potentialAction potential Voltage gated ion channels open and let Na+ into the Voltage gated ion channels open and let Na+ into the

cell. They are driven into the cell because of diffusion cell. They are driven into the cell because of diffusion gradient and electrostatic charge.gradient and electrostatic charge.

This causes the resting potential to reverse, i.e., the This causes the resting potential to reverse, i.e., the inside the cell becomes positive.inside the cell becomes positive.

Now the Na+ ion channels close and the K+ channels Now the Na+ ion channels close and the K+ channels open and the K+ ions are driven out of the cell because open and the K+ ions are driven out of the cell because of their concentration gradient and electrostatic charge. of their concentration gradient and electrostatic charge.

Finally the K+ channels close and the ion pumps kick in Finally the K+ channels close and the ion pumps kick in and the resting potential returns to normal.and the resting potential returns to normal.

Page 14: Chapter 4 - Neuropharmacology

Action potentialAction potential

Page 15: Chapter 4 - Neuropharmacology

All or None LawAll or None Law

Action potentials when they occur are Action potentials when they occur are always the same. always the same.

Once the process is initiated, it must run Once the process is initiated, it must run its course and nothing can stop it or its course and nothing can stop it or change itchange it

Page 16: Chapter 4 - Neuropharmacology

Transmission of action potentials Transmission of action potentials along a membranealong a membrane

When an action potential occurs at one When an action potential occurs at one place on the membrane of an axon, the place on the membrane of an axon, the surrounding membrane is depolarized past surrounding membrane is depolarized past threshold causing an action potential. This threshold causing an action potential. This depolarizes the neighboring membrane, depolarizes the neighboring membrane, etc. etc.

Action potentials sweep across a Action potentials sweep across a membrane as fast as 100m/secmembrane as fast as 100m/sec

Page 17: Chapter 4 - Neuropharmacology

Transmission of action potentials Transmission of action potentials along a membranealong a membrane

Page 18: Chapter 4 - Neuropharmacology

Postsynaptic potentialsPostsynaptic potentials

The membranes of dendrites and cell The membranes of dendrites and cell bodies do not have action potentials. bodies do not have action potentials. Instead, any depolarizing stimulus causes Instead, any depolarizing stimulus causes a post synaptic potential (PSP) which a post synaptic potential (PSP) which spreads out across the membrane. The spreads out across the membrane. The depolarization is weaker the further it gets depolarization is weaker the further it gets from the stimulus. When the stimulus is from the stimulus. When the stimulus is turned off, the PSP disappears.turned off, the PSP disappears.

Page 19: Chapter 4 - Neuropharmacology

Postsynaptic potentialsPostsynaptic potentials

Postsynaptic potentials can either be Postsynaptic potentials can either be excitatory (depolarization) or inhibitory.excitatory (depolarization) or inhibitory.

Excitatory and inhibitory potentials can Excitatory and inhibitory potentials can summate both in time (summate both in time (temporal temporal summationsummation) and across the membrane ) and across the membrane ((spatial summationspatial summation) .) .

The net effect of summation is reflected at The net effect of summation is reflected at the axon hillock where action potentials the axon hillock where action potentials are generated.are generated.

Page 20: Chapter 4 - Neuropharmacology

The synapseThe synapse

Normally, cell bodies are stimulated by Normally, cell bodies are stimulated by either byeither by stimuli in the environment, e.g. sensory cells stimuli in the environment, e.g. sensory cells

like the rods and cones in the eye, orlike the rods and cones in the eye, or Connections from other nerve cells, i.e., Connections from other nerve cells, i.e.,

synapsessynapses

Page 21: Chapter 4 - Neuropharmacology

The SynapseThe Synapse

Page 22: Chapter 4 - Neuropharmacology

The SynapseThe Synapse

Page 23: Chapter 4 - Neuropharmacology

SynapseSynapse

Any neuron can have thousands of synapses on it

Page 24: Chapter 4 - Neuropharmacology

SynapseSynapse

When an action potential arrives at the When an action potential arrives at the terminal terminal boutonbouton, it causes Ca++ channels to open., it causes Ca++ channels to open.

This causes the vesicles to move to the This causes the vesicles to move to the membrane and release a chemical called a membrane and release a chemical called a neurotransmitterneurotransmitter to be released into the to be released into the synaptic cleft.synaptic cleft.

The neurotransmitter diffuses across the cleft The neurotransmitter diffuses across the cleft and activates receptors on the postsynaptic and activates receptors on the postsynaptic membrane which cause changes on the resting membrane which cause changes on the resting potential by altering the functioning of ion potential by altering the functioning of ion channels. channels.

Page 25: Chapter 4 - Neuropharmacology

ProteinsProteins

Ion pumps, ion channels, etc., are large Ion pumps, ion channels, etc., are large molecules of protein.molecules of protein.

Proteins are long strings of amino acids that can Proteins are long strings of amino acids that can fold into many three dimensional shapes. The fold into many three dimensional shapes. The same protein can have different configurations, same protein can have different configurations, i.e., they can change shape. i.e., they can change shape.

Receptors are protein molecules that change Receptors are protein molecules that change shape (are activated) by neurotransmitter shape (are activated) by neurotransmitter molecules with a particular shape.molecules with a particular shape.

Page 26: Chapter 4 - Neuropharmacology

ReceptorsReceptors

Receptor sites can be Receptor sites can be part of an ion channel part of an ion channel and when the and when the receptor site is receptor site is occupied by a occupied by a neurotransmitter, the neurotransmitter, the ion channel opension channel opens

Page 27: Chapter 4 - Neuropharmacology

Post synaptic potentialPost synaptic potential

The change in the resting potential caused by The change in the resting potential caused by the activation of a receptor site is called the post the activation of a receptor site is called the post synaptic potential (PSP). synaptic potential (PSP).

IPSP – when the change causes IPSP – when the change causes hyperpolarization or makes the cell harder to hyperpolarization or makes the cell harder to fire, this is called an inhibitory post synaptic fire, this is called an inhibitory post synaptic potential.potential.

EPSP – when the change causes depolarization, EPSP – when the change causes depolarization, this is called an excitatory post synaptic this is called an excitatory post synaptic potential.potential.

Page 28: Chapter 4 - Neuropharmacology

Post synaptic potentialPost synaptic potential

The excitation and inhibition caused by all The excitation and inhibition caused by all the active synapses on the dendrites and the active synapses on the dendrites and cell body are summed and the net effect cell body are summed and the net effect is reflected in the rate at which the axon is reflected in the rate at which the axon hillock generates action potentialshillock generates action potentials

Page 29: Chapter 4 - Neuropharmacology

SummationSummation

Page 30: Chapter 4 - Neuropharmacology

Terminating synaptic actionTerminating synaptic action

Once the neurotransmitter is released into Once the neurotransmitter is released into the cleft, there must be a means by which the cleft, there must be a means by which its activity is terminated. This can be its activity is terminated. This can be accomplished two waysaccomplished two ways The neurotransmitter can be destroyed by an The neurotransmitter can be destroyed by an

enzyme in the cleftenzyme in the cleft The neurotransmitter can be reabsorbed back The neurotransmitter can be reabsorbed back

into the bouton (reuptake).into the bouton (reuptake).

Page 31: Chapter 4 - Neuropharmacology

Second messengerSecond messenger

The neurotransmitter causes the release of a molecule inside the cell which activates an ion channel and causes it to open

Page 32: Chapter 4 - Neuropharmacology

Second messenger cascadeSecond messenger cascade

Page 33: Chapter 4 - Neuropharmacology

Second messenger cascadeSecond messenger cascade Second messenger molecules can activate a Second messenger molecules can activate a

kinasekinase which lasts for minutes and hours. which lasts for minutes and hours.

Kinases can activate Kinases can activate transcription factorstranscription factors (CREB and c-fos) which alter the expression of (CREB and c-fos) which alter the expression of genes.genes.

Genes carry the codes for the creation of Genes carry the codes for the creation of proteins including ion channels and receptor proteins including ion channels and receptor sites and this can cause permanent changes in sites and this can cause permanent changes in synaptic function.synaptic function.

Page 34: Chapter 4 - Neuropharmacology

autoreceptorsautoreceptors

The membrane of the presynaptic cell has The membrane of the presynaptic cell has many receptor sites which detect the many receptor sites which detect the neurotransmitter. This is a feedback neurotransmitter. This is a feedback system which regulated the amount of system which regulated the amount of neurotransmitter released into the cleftneurotransmitter released into the cleft

Page 35: Chapter 4 - Neuropharmacology

Other signaling between neuronsOther signaling between neurons

Neuromodulators are chemicals that can alter the effect of Neuromodulators are chemicals that can alter the effect of a neurotransmitter.a neurotransmitter.

Sometimes the postsynaptic membrane releases molecules Sometimes the postsynaptic membrane releases molecules that affect the presynaptic membrane. that affect the presynaptic membrane. DSE- depolarization-induced suppression of excitationDSE- depolarization-induced suppression of excitation

DSI – depolarization-induced suppression of inhibition.DSI – depolarization-induced suppression of inhibition.

Axo-axonal synapses: axons may also have synapsesAxo-axonal synapses: axons may also have synapses

Page 36: Chapter 4 - Neuropharmacology

Neurotransmitters

Acetylcholine (Ach)

Biogenic amines (monoamines)catecholamines:

Norepinephrine (NE)Dopamine (DA)Epinephrine (E) (adrenaline)

indoleamineSerotonin (5-HT, 5-hydroxytryptamine)

Page 37: Chapter 4 - Neuropharmacology

Amino acids:GABAGlycineGlutamateProline

Page 38: Chapter 4 - Neuropharmacology

PeptidesSubstance PSomatostatinVasopressinGrowth hormoneProlactinInsulinOpiate-like transmitters

EnkephalinsEndorphins

Page 39: Chapter 4 - Neuropharmacology

carbon monoxide

nitric oxide

Page 40: Chapter 4 - Neuropharmacology

Many hormones are neurotransmitters. Both have the same function: chemical signalling over distances.

Page 41: Chapter 4 - Neuropharmacology

Neurohormones

Substances that act at neuron receptor sites, but are not specific to an individual synapse.

May be released far from the synapse.

Act as a neuromodulator (modify the activity of a neurotransmitter)

Page 42: Chapter 4 - Neuropharmacology

Dale’s Law

A single neuron always produces the same transmitter at every one of its synapses.

It is now known that the law is not always right.

Page 43: Chapter 4 - Neuropharmacology

Drugs mostly act on the nervous system by interacting with neurotransmission,They may:act on receptor sites and cause the same effect as a transmitter: agonismblock a receptor site: antagonismdecreasing activity of enzymes that destroy a transmitterblock reuptake mechanismsblocking ion channelsaltering release of transmitteraltering the action of neurohormones

Page 44: Chapter 4 - Neuropharmacology

Synapses that use NE are nor adrenergic (remember, adrenaline is another word for epinephrine)

DA are dopaminergic 5-HT are serotonergic ACh are cholinergic etc

Page 45: Chapter 4 - Neuropharmacology

Acetylcholine:

Broken down by AchE (acetylcholinesterase)

Receptors: nicotinic and muscarinic

Stimulated Blocked Function

nicotinic nicotine curare Voluntary muscle control

(neuromuscular junctions)

muscarinic muscarine atropine Involuntary muscle control

botox and nerve gasses

Page 46: Chapter 4 - Neuropharmacology

Biogenic aminesSerotonin, Dopamine Norepinephrine and

EpinephrineBroken down by MAO and COMTReabsorbed by transporter mechanisms

Influenced by amphetamines and cocaine and SSRIs and SNRIs

E and NE receptor sites alpha (α)and Beta (β) with subtypes 1 and 2DA has 6 receptor subtypes D1 and D2....D6 with sub sub types a b c, etcSerotonin has 4 main receptor subtypes with sub sub types a b c etc.

Page 47: Chapter 4 - Neuropharmacology

GABAGABA

Universally inhibitory transmitterUniversally inhibitory transmitter Opens a Chloride ion channel which stabilizes the Opens a Chloride ion channel which stabilizes the

membrane and makes it harder to depolarizemembrane and makes it harder to depolarize Drugs like benzodiazepines enhance the ability of GABA Drugs like benzodiazepines enhance the ability of GABA

to open the ion channel. to open the ion channel. There are two types of GABA receptors; GABAA and There are two types of GABA receptors; GABAA and

GABAB. GABAB. There are many different subtypes of GABAA receptors There are many different subtypes of GABAA receptors

which control different functions.which control different functions. GABAB receptors are less common and use a second GABAB receptors are less common and use a second

messengermessenger

Page 48: Chapter 4 - Neuropharmacology

GABAGABA

Page 49: Chapter 4 - Neuropharmacology

Glutamateexcitatory transmitterNMDA receptor open ion channel and lets +ions

into the cellthe channels can be blocked by alcohol, solvents

and some hallucinogens

Peptidesopioid type peptides

enkephalins (5 amino acids)endorphines (16 to 30 amino acids)

Receptor subtypes mu, kappa and delta

Page 50: Chapter 4 - Neuropharmacology

The Nervous System

Central Nervous System (CNS)brain and spinal cord

Peripheral Nervous system (PNS)everything else

Page 51: Chapter 4 - Neuropharmacology

somatic NSconscious senses and voluntary muscles transmitter is Ach and uses nicotinic receptors

autonomic NS unconscious senses and involuntary musclestransmitter is Ach with muscarinic receptors.

Page 52: Chapter 4 - Neuropharmacology

Autonomic NSsympathetic and parasympathetic divisions

Parasympatheticalways active,controls daily vegetative functions Ach major transmittersome drugs have “anticholinergic” side effects,

e.g dry mouth and blurry vision

Sympatheticactive at times of fear and angerfight - flight responseepinephrine (E) major transmitter

Page 53: Chapter 4 - Neuropharmacology

CNSspinal cord

Brain100 billion neurons. each has 100 synapses on

other neurons and receives 10,000 synapses from other neurons

Page 54: Chapter 4 - Neuropharmacology

Spinal cordSpinal cord

Page 55: Chapter 4 - Neuropharmacology

BrainBrain

Page 56: Chapter 4 - Neuropharmacology

Medulla:

Autonomic control centre:

Respiratory centre controls breathing

Vomiting centre

Cardiac functions

Very sensitive to “depressant” drugs like alcohol, opioids and barbiturates

Brain damage caused by drug overdose is a result of lack of oxygen

Page 57: Chapter 4 - Neuropharmacology

RAS and Raphé System

RAS ‑ arousal- many interconnected centres- diffuse projection to cortex and higher centres

Raphé System- many independent centres- serotonin- medial forebrain bundle projects forward

‑ sleep ‑ mood

Page 58: Chapter 4 - Neuropharmacology

Locus Coeruleus

mood: fear, panic, angerprimarily NE, (50 to 75% NE neurons in the brain)stimulated by monoaminesinhibited by GABAactive during panic attack

Page 59: Chapter 4 - Neuropharmacology
Page 60: Chapter 4 - Neuropharmacology

Cerebellum:

Coordination of motor control

Receives input from the motor areas of the cortex and the muscles and coordinates smooth muscle movement.

Coordinates eye movements.

Page 61: Chapter 4 - Neuropharmacology

Basal Ganglia:Input side:striatum – caudate nucleus and putamen

- input from thalamus and cortexOutput side:globus palladus - output side with feedback to thalamus“Motor loop”

coordination of motor control- DA input from substantia nigra- DA receptors- DA deficiency ‑ Parkinsons Disease- extrapyramidal motor system

Page 62: Chapter 4 - Neuropharmacology
Page 63: Chapter 4 - Neuropharmacology

Periaquiductal gray:

pain control - mu receptors and morphine-like transmitters punishment system

Page 64: Chapter 4 - Neuropharmacology

Limbic system:

hypothalamus - eating and drinking control

medial forebrain bundle‑‑‑ reinforcement (pleasure?) centres

mesolimbic system (DA)ventral tegmental area (VTA, mu receptors)nucleus accumbens

hippocampus - learning and memory

amygdala and septum - serotonergic input from the Raphé system Aggression and emotion Inhibited by GABA

Page 65: Chapter 4 - Neuropharmacology

CortexCortex

Cortex

sensory input areasmotor control output areaslanguagememory and thinking

glutamate ‑ excitatory transmitterGABA ‑ inhibitory transmitter

Page 66: Chapter 4 - Neuropharmacology

Frontal and prefrontal cortexFrontal and prefrontal cortexFrontal and prefrontal cortex: monitors relationship between cues and reinforces (outcomes of behavior), inhibition of behavior and the expression of emotion.

Orbitofrontal cortex: learning and behavior control

Prefrontal cortex: working memory, attention, decision making, reasoning, planning and judgment.

Dorsolateral prefrontal cortex: maintenance of attention and manipulation

Anderior cingulate cortex: attention, response selection, response suppression, drug seeking and craving.

Page 67: Chapter 4 - Neuropharmacology

DevelopmentDevelopment

Formation of neurons

Migration

Attachment and axon projection

Growth cone

Page 68: Chapter 4 - Neuropharmacology

Development and teratologyDevelopment and teratology

Extension of axons is controlled by trophic factors, chemical signals that guide it to its target.

These signals can be easily disrupted by drugs and cause incorrect wiring of the CNS

Eg: fetal; alcohol syndrome – only 4 layers rather than the normal 6 in the cortex.

Teratology: disruption of normal anatomical development, e.g thalidomide

Functional teratology: a disruption of normal behavioral development.

Page 69: Chapter 4 - Neuropharmacology